4//SEC Filing
Sjuts Dustin S 4
Accession 0001479290-23-000019
CIK 0001479290other
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 8:29 PM ET
Size
4.8 KB
Accession
0001479290-23-000019
Insider Transaction Report
Form 4
Sjuts Dustin S
Chief Commercial Officer
Transactions
- Tax Payment
Common Stock
2023-02-15$33.21/sh−2,766$91,859→ 93,046 total
Footnotes (1)
- [F1]Represents the number of shares withheld by and surrendered to the Issuer on February 15, 2023, to satisfy tax withholding obligations that arose in connection with the vesting of a Restricted Stock award (the "RSA") for 6,667 shares. The RSA vested in three equal annual installments from February 15, 2020.
Documents
Issuer
Revance Therapeutics, Inc.
CIK 0001479290
Entity typeother
Related Parties
1- filerCIK 0001796224
Filing Metadata
- Form type
- 4
- Filed
- Feb 15, 7:00 PM ET
- Accepted
- Feb 16, 8:29 PM ET
- Size
- 4.8 KB